Recent News

• 04.02.2025 - Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
• 03.13.2025 - Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates
• 02.04.2025 - Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 01.29.2025 - Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)
• 01.29.2025 - Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)

Recent Filings

• 03.27.2025 - EX-99.1 EX-99.1
• 03.27.2025 - 8-K Current report
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 8-K Current report
• 03.04.2025 - 8-K Current report
• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities